Jul 1 |
Bird Flu Vaccine Faces Hurdles Without Better Data, Critics Say
|
Jul 1 |
Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
|
Jun 30 |
Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?
|
Jun 30 |
Moderna: Really Strong Competition
|
Jun 28 |
CDC Narrows Age Recommendation for Use of RSV Vaccine
|
Jun 28 |
Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
|
Jun 28 |
Carisma jumps as drug discovery under Moderna deal leads to $2M payment
|
Jun 28 |
Moderna RSV vaccine endorsed in EU
|
Jun 28 |
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
|
Jun 27 |
Moderna (MRNA) Shares Decline on RSV Vaccine Efficacy Data
|